Campbell & Associates is here to help with your Product Liability Case.

ACTOS is a Type 2 (adult onset) diabetes drug linked to the development of bladder cancer in long-term users.  Patients taking Actos (or a related medicine) for more than a year who develop bladder cancer may have a claim for damages against Takeda Pharmaceutical (the manufacturer) and Eli Lilly who co-markets the drug in the U.S.  The FDA first warned doctors and patients in July of 2011 that using the drug for more than one year may be linked to an increased risk of bladder cancer and required that an additional warning be put on the packaging based on a review of a 10 year study showing that there may be a 40% increased risk of bladder cancer if Actos is taken for more than 1 year.  Sales of Actos have been banned or suspended in France and Germany for this very reason.

Other medications that contain ACTOS include ACTOPLUS MET, ACTOPLUS MET XR AND DUETACT.

ACTOS  was first approved by the FDA in July of 1999 and is in the class of drugs known as TZD (thiazolidinediones).  Its scientific name is pioglitazone hydrochloride.  It is still being sold in the U.S.

If you or a loved developed Actos bladder cancer, contact a Charlotte personal injury lawyer to protect your legal right to compensation.  Campbell & Associates is actively accepting Actos bladder cancer cases. Call 704-333-0885 to schedule an appointment in one of our convenient office locations in Charlotte, Gastonia, Hickory and Rock Hill, SC.